Standard Biotools | FLDM - Current Liabilities



Standard Biotools reported $98.02M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Agilent USD 1.89B 120M Jul/2025
Becton, Dickinson and Co. USD 8.16B 469M Jun/2025
Bio-Rad Laboratories USD 548.9M 42.3M Jun/2025
Bruker USD 1.35B 2.5M Jun/2025
Danaher USD 6.79B 147M Jun/2025
Illumina USD 1.46B 21M Jun/2025
Myriad Genetics USD 151.1M 13M Mar/2025
Nikon Corporation JPY 319.21B 13.66B Jun/2025
Revvity USD 671.81M 23.63M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Sony JPY 24.11T 13.42T Jun/2025
Standard Biotools USD 98.02M 32.13M Jun/2025
Thermo Fisher Scientific USD 12.72B 456M Jun/2025
Waters USD 1.02B 55.16M Jun/2025